Sentinel lymph node mapping identifies positive lymph nodes in women with high-risk endometrial cancer, MD Anderson study finds
Research offers promise for less invasive staging tool, future management of disease
MD Anderson News Release 03/31/2015
In a study of women with high-grade endometrial cancer, researchers at Âé¶¹Ó³» MD Anderson Cancer Center, found sentinel lymph node (SLN) mapping accurately identified all women with node-positive, high-risk endometrial cancer, when prospectively compared to a complete pelvic and...
Cancer immunotherapy innovator Jim Allison wins 2015 Paul Ehrlich and Ludwig Darmstaedter Prize
MD Anderson News Release 03/16/2015
Jim Allison, Ph.D., chair of Immunology at Âé¶¹Ó³» MD Anderson Cancer Center, received...
MD Anderson study predicts new hepatitis C drugs will place a dramatic financial strain on the health care system
MD Anderson News Release 03/16/2015
NOTE TO MEDIA: This study was finalized prior to FDA approval of AbbVie¡¯s HCV drug, and of...
Hippo ¡®Crosstalk¡¯ May Be Vital to Tumor Suppression
MD Anderson Study Reveals New Understanding of Key Cell-Signaling Pathway
MD Anderson News Release 03/09/2015
Think of a waterfall, and you might see why cell-signaling pathways are important to cancer research. As water cascades, it impacts everything downstream. And everything upstream affects the waterfall.
Cell-signaling pathways are similar in that one molecular action results in another, and another, ultimately...
MD Anderson Study Shows Why Some Brain Cancers Resist Treatment
MD Anderson News Release 03/02/2015
Scientists at Âé¶¹Ó³» MD Anderson Cancer Center may have discovered why some...